BackRenovoRx Overview

RenovoRx Accounts Payable

Track RenovoRx's accounts payable ($870K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$866000.00
↑ 29.06% YoYΔ $195000.00 vs prior year quarter

Peer trimmed avg / median

Loading

RenovoRx Accounts Payable History

Loading

RenovoRx vs. peers: Accounts Payable Comparison

Loading

RenovoRx Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

RenovoRx (RNXT) FAQ

The latest accounts payable for RNXT is $870K as of June 2026. That compares with $670K in the prior-year period — up 29.1% year over year. Investors often review this figure alongside RenovoRx's historical trend and sector peers before judging valuation or financial health.

Over the past year, RNXT's accounts payable moved from $670K to $870K — a 29.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RenovoRx's operating scale or balance-sheet position.

A accounts payable figure of $870K for RNXT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RNXT's accounts payable ($870K), review year-over-year change from $670K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.